These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

478 related items for PubMed ID: 16870715

  • 1. Visual loss with erectile dysfunction medications.
    Wooltorton E.
    CMAJ; 2006 Aug 15; 175(4):355. PubMed ID: 16870715
    [No Abstract] [Full Text] [Related]

  • 2. Ophthalmic aspects of erectile dysfunction drugs.
    Verit A, Oguz H.
    Am J Ophthalmol; 2006 Mar 15; 141(3):598; author reply 599. PubMed ID: 16490529
    [No Abstract] [Full Text] [Related]

  • 3. Non-arteritic anterior ischemic optic neuropathy, erectile dysfunction drugs, and amiodarone: is there a relationship?
    Fraunfelder FW, Shults T.
    J Neuroophthalmol; 2006 Mar 15; 26(1):1-3. PubMed ID: 16518158
    [No Abstract] [Full Text] [Related]

  • 4. Sildenafil-associated NAION.
    Gandhi JS.
    Ophthalmology; 2003 Sep 15; 110(9):1860-1; author reply 1861. PubMed ID: 13129901
    [No Abstract] [Full Text] [Related]

  • 5. Review of time of onset and duration of clinical efficacy of phosphodiesterase type 5 inhibitors in treatment of erectile dysfunction.
    Shabsigh R, Seftel AD, Rosen RC, Porst H, Ahuja S, Deeley MC, Garcia CS, Giuliano F.
    Urology; 2006 Oct 15; 68(4):689-96. PubMed ID: 17070333
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Rates of non-arteritic ischemic optic neuropathy in male veterans prescribed phosphodiesterase-5 inhibitors.
    Tsertsvadze A.
    Am J Ophthalmol; 2009 Oct 15; 148(4):625; author reply 625-6. PubMed ID: 19782802
    [No Abstract] [Full Text] [Related]

  • 8. FDA updates labeling for erectile dysfunction drugs.
    FDA Consum; 2005 Oct 15; 39(5):3. PubMed ID: 16419280
    [No Abstract] [Full Text] [Related]

  • 9. Unilateral optic neuropathy associated with sildenafil intake.
    Gruhn N, Fledelius HC.
    Acta Ophthalmol Scand; 2005 Feb 15; 83(1):131-2. PubMed ID: 15715581
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Erectile dysfunction drugs and non-arteritic anterior ischemic optic neuropathy: is there a cause and effect relationship?
    Hayreh SS.
    J Neuroophthalmol; 2005 Dec 15; 25(4):295-8. PubMed ID: 16340497
    [Abstract] [Full Text] [Related]

  • 12. Can erectile dysfunction drug use lead to ischaemic optic neuropathy?
    Pomeranz HD.
    Br J Ophthalmol; 2006 Feb 15; 90(2):127-8. PubMed ID: 16424515
    [Abstract] [Full Text] [Related]

  • 13. Visual field defect and intracerebral hemorrhage associated with use of vardenafil (Levitra).
    Hellstrom WJ.
    Neurology; 2006 Jan 24; 66(2):293-4; author reply 293-4. PubMed ID: 16434684
    [No Abstract] [Full Text] [Related]

  • 14. Viagra and anterior ischemic optic neuropathy.
    Egan RA, Fraunfelder FW.
    Arch Ophthalmol; 2005 May 24; 123(5):709-10. PubMed ID: 15883302
    [No Abstract] [Full Text] [Related]

  • 15. Pills for erectile dysfunction: now there are three.
    Harv Mens Health Watch; 2004 Apr 24; 8(9):5-6. PubMed ID: 15100064
    [No Abstract] [Full Text] [Related]

  • 16. Viagra and loss of vision.
    Med Lett Drugs Ther; 2005 Jun 20; 47(1211):49. PubMed ID: 15961969
    [No Abstract] [Full Text] [Related]

  • 17. Erectile dysfunction drugs and nonarteritic anterior ischemic optic neuropathy.
    Lee AG, Newman NJ.
    Am J Ophthalmol; 2005 Oct 20; 140(4):707-8. PubMed ID: 16226524
    [No Abstract] [Full Text] [Related]

  • 18. Phosphodiesterase 5 inhibitors for erectile dysfunction.
    Setter SM, Iltz JL, Fincham JE, Campbell RK, Baker DE.
    Ann Pharmacother; 2005 Oct 20; 39(7-8):1286-95. PubMed ID: 15941818
    [Abstract] [Full Text] [Related]

  • 19. Phosphodiesterase inhibitors for erectile dysfunction in patients with diabetes mellitus.
    Vardi M, Nini A.
    Cochrane Database Syst Rev; 2007 Jan 24; 2007(1):CD002187. PubMed ID: 17253475
    [Abstract] [Full Text] [Related]

  • 20. Phosphodiesterase type 5 inhibitors' extended duration of response as a variable in the treatment of erectile dysfunction.
    Dunn ME, Althof SE, Perelman MA.
    Int J Impot Res; 2007 Jan 24; 19(2):119-23. PubMed ID: 16738695
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.